bioRxivSynthetic BiologyPreprint
Programming Targeted Immune Cell Migration Using Orthogonal Chemokine-Receptor Pairs
Jungmin LeeiD, Karthik SrinivasaniD, Claudia Llinás del TorrentiD, Debraj GhoseiD, Devan H ShahiD, Luis Oliva Hernandez, Sarah Wasinger, Michelle ChangiD, Wei YuiD, Yurie TonaiiD, Francis C. PetersoniD, Martyna SzpakowskaiD, Andy ChevignéiD, Brian F. VolkmaniD, Aashish ManglikiD, Wendell A. LimiD
Abstract
Chemokines orchestrate the migration of immune cells throughout the body, but harnessing chemokine signaling to engineer targeted cell trafficking is challenging because of their overlapping interactions and broad expression patterns. Here we used structure-guided protein design to engineer orthogonal chemokine-receptor pairs with minimal crosstalk to native systems. T cells engineered with an ortho-receptor selectively infiltrated tissues producing the ortho-chemokine, in vitro and in vivo. By engineering T cells that both sense and secrete the ortho-chemokine, we generated collective swarming behavior in which pioneer cells attract follower cells via an ortho-chemokine gradient self-organized by positive feedback. By providing orthogonal genetic control over both the generation and sensing of chemokine gradients, this system enables the construction of autonomous spatial targeting programs in engineered cells.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Self-generated chemotaxis of mixed cell populations
Mehmet Can Uçar, Zane Alsberga, … Édouard Hannezo·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 21, 2025
- Live-cell microscopy reveals that human T cells primarily respond chemokinetically within a CCL19 gradient that induces chemotaxis in dendritic cells
E. J. Loef, H. M. Sheppard, … R. P. Dunbar·bioRxiv·Nov 8, 2020
- Torque-based immune cell chemotaxis in complex environments
Theresa Jakuszeit, Mathieu Deygas, … Matthieu Piel·bioRxiv·Nov 21, 2025
- Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer Cells
N. Diwanji, D. Getts, Y. Wang·bioRxiv·Nov 7, 2023
- Engineered bacteria recruit and orchestrate anti-tumor immunity
T. M. Savage, R. L. Vincent, … N. Arpaia·bioRxiv·Jun 16, 2022
- IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy
Hua Jiang, Sam P. Limsuwannarot, … Anusha K. Kalbasi·ImmunityPeer-reviewed·Nov 21, 2025